BioNTech SE - ADR vs Northrop Grumman Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Northrop Grumman Corporation trades at $575.54 (market cap $81.78B). The key difference: Northrop Grumman Corporation is far larger — about 3.5× BioNTech SE - ADR's market cap, and Northrop Grumman Corporation pays a 1.63% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | NOC | |
|---|---|---|
Market Cap | $23.31B | $81.78B |
Sector | Health | Industrials |
52-Week High | $119.34 | $768.02 |
52-Week Low | $83.89 | $496.02 |
Enterprise Value | $6.60B | $95.77B |
Dividend Yield | — | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →